J&J’s Drug Settlement for $1 Billion Is Rejected
March 12, 2012 | Posted By: Sean Estes
Federal prosecutors in Washington, D.C., have rejected a roughly $1 billion proposed settlement to resolve allegations that Johnson & Johnson promoted the antipsychotic drug Risperdal for unapproved uses, according to people familiar with the matter. J&J and the federal prosecutors in Philadelphia who had reached the tentative deal now must go back to the drawing board, because […]
Learn More